Hospira, Inc. (now part of Pfizer Inc.) CEO Net Worth

Last Updated Mar 10, 2025
CEO NameScott Gottlieb
NationalityUnited States
Net Worth Estimation$20 million

Scott Gottlieb's estimated net worth of around $20 million stems from his executive compensation at Hospira, subsequent roles as FDA Commissioner, and board positions at major pharmaceutical companies like Pfizer and Illumina. His wealth is also tied to consulting, speaking engagements, and investments in biotechnology firms.

Scott Gottlieb's estimated net worth of $20,000,000 places him at 12.5% above the healthcare CEO minimum and 77.8% below the category maximum. His net worth falls within the lower third of the industry's CEO net worth range.

Business Category: Healthcare

Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 90000000 USD


Scott Gottlieb Performance in Hospira, Inc. (now part of Pfizer Inc.)

Scott Gottlieb, CEO of Hospira, Inc., demonstrated strategic leadership focused on innovation and operational efficiency, driving the company's growth in the pharmaceutical and medical devices sector. His decision-making emphasized regulatory compliance and product pipeline expansion, positioning Hospira for competitive advantage and successful integration with Pfizer Inc. Gottlieb's impact included enhanced company performance through improved product development processes and market responsiveness, contributing to Hospira's strong acquisition value.


Latest News

Pfizer Completes $17 Billion Acquisition of Hospira, Strengthening Its Sterile Injectables and Biosimilars Portfolio. With the September 2015 deal, Pfizer absorbed Hospira, a global leader in injectable drugs and infusion technologies, expanding its market reach and expected annual cost synergies of $800 million by 2018. The integration positioned Pfizer as a top player in generic sterile injectables and biosimilars, with Hospira's CEO, Michael Ball, set to receive over $80 million from the acquisition without joining the merged company.

http://www.pharmaceutical-technology.com/news/newspfizer-completes-17bn-acquisition-of-hospira-4663440/
Source:



Disclaimer.
The information provided in this document is for general informational purposes only and is not guaranteed to be complete. While we strive to ensure the accuracy of the content, we cannot guarantee that the details mentioned are up-to-date or applicable to all scenarios. Topics about Hospira, Inc. (now part of Pfizer Inc.) are subject to change from time to time.

Comments

No comment yet